Skin Cancer & Melanoma

Latest News

Treatment with isolated hepatic perfusion appears to yield improved progression-free survival compared with best alternative care in patients with isolated uveal melanoma liver metastases.
Isolated Hepatic Perfusion Yields Responses in Melanoma Liver Metastases

May 7th 2023

Treatment with isolated hepatic perfusion appears to yield improved progression-free survival compared with best alternative care in patients with isolated uveal melanoma liver metastases.

The 31-gene expression profile test appears to allow for significant and independent risk stratification of those with stage I cutaneous melanoma.
Gene Profile Test May Improve Risk Stratification in Cutaneous Melanoma

April 27th 2023

Tavokinogene telseplasmid plus pembrolizumab is reported to be well tolerated in patients with advanced, pre-treated melanoma based on data from the phase 2 KEYNOTE-695 trial.
Tavokinogene/Pembrolizumab Yields Responses but Misses End Point in Melanoma

April 11th 2023

Patients with metastatic or recurrent locally advanced Merkel cell carcinoma can now receive treatment with retifanlimab-dlwr following its approval by the FDA.
FDA Grants Accelerated Approval to Retifanlimab-dlwr for Merkel Cell Carcinoma

March 22nd 2023

Nivolumab/Relatlimab Yields Long-Lasting Activity in Pretreated Melanoma | Image Credit: © David A Litman - stock.adobe.com.
Nivolumab/Relatlimab Yields Long-Lasting Activity in Pretreated Melanoma

March 20th 2023

Video Series
Video Interviews
Podcasts
OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma
On this episode of CancerNetwork’s podcast, Emily Smith, MD, discussed a patient case of basal cell carcinoma she and colleagues published in the journal ONCOLOGY.

More News